These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28135089)

  • 21. Integrin specificity and enhanced cellular activities associated with surfaces presenting a recombinant fibronectin fragment compared to RGD supports.
    Petrie TA; Capadona JR; Reyes CD; García AJ
    Biomaterials; 2006 Nov; 27(31):5459-70. PubMed ID: 16846640
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction Mechanism and Clustering among RGD Peptides and Integrins.
    Dong X; Yu Y; Wang Q; Xi Y; Liu Y
    Mol Inform; 2017 May; 36(5-6):. PubMed ID: 28004516
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Concept and progress in the development of RGD-containing peptide pharmaceuticals.
    Craig WS; Cheng S; Mullen DG; Blevitt J; Pierschbacher MD
    Biopolymers; 1995; 37(2):157-75. PubMed ID: 7534489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective, tight-binding inhibitors of integrin alpha4beta1 that inhibit allergic airway responses.
    Lin Kc; Ateeq HS; Hsiung SH; Chong LT; Zimmerman CN; Castro A; Lee WC; Hammond CE; Kalkunte S; Chen LL; Pepinsky RB; Leone DR; Sprague AG; Abraham WM; Gill A; Lobb RR; Adams SP
    J Med Chem; 1999 Mar; 42(5):920-34. PubMed ID: 10072689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrin-Targeting Fluorescent Proteins: Exploration of RGD Insertion Sites.
    Sonntag MH; Schill J; Brunsveld L
    Chembiochem; 2017 Mar; 18(5):441-443. PubMed ID: 28004511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of osteoclast-mediated bone resorption through occupancy of the integrin receptor: a potential approach to the therapy of osteoporosis.
    Dresner-Pollak R; Rosenblatt M
    J Cell Biochem; 1994 Nov; 56(3):323-30. PubMed ID: 7876325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A tetravalent RGD ligand for integrin-mediated cell adhesion.
    Watson N; Duncan G; Annan WS; van der Walle CF
    J Pharm Pharmacol; 2006 Jul; 58(7):959-66. PubMed ID: 16805956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimized conventional synthesis of "RGD" and "RGDS" peptides and their sarcosine mimics as integrin GP IIb/IIIa antagonists.
    Abo-Ghalia M; Abd El-Rahman S; El-Kafrawy A; Kalomuch A
    Amino Acids; 2003 Jun; 24(4):405-11. PubMed ID: 12768503
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arginine-glycine-aspartic acid (RGD)-containing peptides inhibit the force production of mouse papillary muscle bundles via alpha 5 beta 1 integrin.
    Sarin V; Gaffin RD; Meininger GA; Muthuchamy M
    J Physiol; 2005 Apr; 564(Pt 2):603-17. PubMed ID: 15718258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent progress in biomedical applications of RGD-based ligand: From precise cancer theranostics to biomaterial engineering: A systematic review.
    Alipour M; Baneshi M; Hosseinkhani S; Mahmoudi R; Jabari Arabzadeh A; Akrami M; Mehrzad J; Bardania H
    J Biomed Mater Res A; 2020 Apr; 108(4):839-850. PubMed ID: 31854488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RGD and other recognition sequences for integrins.
    Ruoslahti E
    Annu Rev Cell Dev Biol; 1996; 12():697-715. PubMed ID: 8970741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrin inhibitors from snake venom: exploring the relationship between the structure and activity of RGD-peptides.
    Wermelinger LS; Geraldo RB; Frattani FS; Rodrigues CR; Juliano MA; Castro HC; Zingali RB
    Arch Biochem Biophys; 2009 Feb; 482(1-2):25-32. PubMed ID: 19101499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and chemical synthesis of integrin ligands.
    Heckmann D; Kessler H
    Methods Enzymol; 2007; 426():463-503. PubMed ID: 17697896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-peptide RGD surrogates which mimic a Gly-Asp beta-turn: potent antagonists of platelet glycoprotein IIb-IIIa.
    Fisher MJ; Gunn B; Harms CS; Kline AD; Mullaney JT; Nunes A; Scarborough RM; Arfsten AE; Skelton MA; Um SL; Utterback BG; Jakubowski JA
    J Med Chem; 1997 Jun; 40(13):2085-101. PubMed ID: 9207949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiosynthesis and micro-SPECT analysis of triazole-based RGD integrin ligands as non-peptide molecular imaging probes for angiogenesis.
    Bianchini F; Fabbrizzi P; Menchi G; Raspanti S; Bottoncetti A; Passeri A; Andreucci E; Guarna A; Calorini L; Pupi A; Trabocchi A
    Bioorg Med Chem; 2015 Mar; 23(5):1112-22. PubMed ID: 25637121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of small molecule leads in a biotechnology datastream.
    Gadek TR; McDowell RS
    Drug Discov Today; 2003 Jun; 8(12):545-50. PubMed ID: 12821302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinatorial chemistry techniques applied to nonpeptide integrin antagonists.
    Hoekstra WJ; Poulter BL
    Curr Med Chem; 1998 Jun; 5(3):195-204. PubMed ID: 9562602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small Cause, Great Impact: Modification of the Guanidine Group in the RGD Motif Controls Integrin Subtype Selectivity.
    Kapp TG; Fottner M; Maltsev OV; Kessler H
    Angew Chem Int Ed Engl; 2016 Jan; 55(4):1540-3. PubMed ID: 26663700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting RGD recognizing integrins: drug development, biomaterial research, tumor imaging and targeting.
    Meyer A; Auernheimer J; Modlinger A; Kessler H
    Curr Pharm Des; 2006; 12(22):2723-47. PubMed ID: 16918408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of amino acids near the RGD sequence on binding activities between αIIbβ3 integrin and fibrinogen in the presence of RGD-containing synthetic peptides from elegantin and angustatin.
    Oyama E; Takahashi H; Ishii K
    Peptides; 2017 Oct; 96():31-37. PubMed ID: 28887046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.